{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:16:27Z","timestamp":1782922587123,"version":"3.54.5"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T00:00:00Z","timestamp":1693958400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jidinnovations.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JID Innovations"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.xjidi.2023.100231","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T09:39:29Z","timestamp":1694511569000},"page":"100231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Targeting the Angiotensin Pathway in the Treatment of Cutaneous Fibrosis: A Systematic Review"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8259-9886","authenticated-orcid":false,"given":"Trenton","family":"Greif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0814-4098","authenticated-orcid":false,"given":"Mouaz","family":"Alsawas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8400-9042","authenticated-orcid":false,"given":"Alexander T.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1987-9521","authenticated-orcid":false,"given":"Vincent","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7197-7260","authenticated-orcid":false,"given":"Larry","family":"Prokop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5502-5975","authenticated-orcid":false,"given":"M. Hassan","family":"Murad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2202-6589","authenticated-orcid":false,"given":"Jennifer G.","family":"Powers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xjidi.2023.100231_bib1","first-page":"1442","article-title":"Comparative results in treatment of keloids with intralesional 5-FU\/Kenalog, 5-FU\/verapamil, enalapril alone,verapamil alone, and laser: a case report and review of the literature","volume":"15","author":"Alexandrescu","year":"2016","journal-title":"J\u00a0Drugs Dermatol"},{"key":"10.1016\/j.xjidi.2023.100231_bib2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.matbio.2016.01.013","article-title":"Keloids: the paradigm of skin fibrosis - pathomechanisms and treatment","volume":"51","author":"Andrews","year":"2016","journal-title":"Matrix Biol"},{"key":"10.1016\/j.xjidi.2023.100231_bib3","doi-asserted-by":"crossref","first-page":"112e","DOI":"10.1097\/PRS.0b013e31819a34db","article-title":"Treatment of a postburn keloid scar with topical captopril: report of the first case","volume":"123","author":"Ardekani","year":"2009","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.xjidi.2023.100231_bib4","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/625376","article-title":"Cutaneous scarring: a clinical review","volume":"2009","author":"Baker","year":"2009","journal-title":"Dermatol Res Pract"},{"key":"10.1016\/j.xjidi.2023.100231_bib5","first-page":"33","article-title":"Keloids: a review of etiology, prevention, and treatment","volume":"13","author":"Betarbet","year":"2020","journal-title":"J\u00a0Clin Aesthet Dermatol"},{"key":"10.1016\/j.xjidi.2023.100231_bib6","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.bjps.2008.03.020","article-title":"The hidden cost of skin scars: quality of life after skin scarring","volume":"61","author":"Brown","year":"2008","journal-title":"J\u00a0Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.xjidi.2023.100231_bib7","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s00266-018-1073-6","article-title":"Comparison of enalapril, candesartan and intralesional triamcinolone in reducing hypertrophic scar development: an experimental study","volume":"42","author":"Demir","year":"2018","journal-title":"Aesthetic Plast Surg"},{"key":"10.1016\/j.xjidi.2023.100231_bib8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s12079-011-0131-5","article-title":"Deconstructing fibrosis research: do pro-fibrotic signals point the way for chronic dermal wound regeneration?","volume":"5","author":"Elliott","year":"2011","journal-title":"J\u00a0Cell Commun Signal"},{"key":"10.1016\/j.xjidi.2023.100231_bib9","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1038\/s41598-018-21600-w","article-title":"Angiotensin-converting enzyme inhibitor reduces scar formation by inhibiting both canonical and noncanonical TGF-\u03b21 pathways","volume":"8","author":"Fang","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.xjidi.2023.100231_bib10","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/archderm.140.11.1401","article-title":"Nephrogenic fibrosing dermopathy: are ACE inhibitors the missing link?","volume":"140","author":"Fazeli","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.xjidi.2023.100231_bib11","first-page":"e43","article-title":"A\u00a0review of scar scales and scar measuring devices","volume":"10","author":"Fearmonti","year":"2010","journal-title":"EPlasty"},{"key":"10.1016\/j.xjidi.2023.100231_bib12","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/j.jisp.2016.10.024","article-title":"Current understanding of the genetic causes of keloid formation","volume":"18","author":"Glass","year":"2017","journal-title":"J\u00a0Investig Dermatol Symp Proc"},{"key":"10.1016\/j.xjidi.2023.100231_bib13","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/exd.14154","article-title":"The renin-angiotensin system in cutaneous hypertrophic scar and keloid formation","volume":"29","author":"Hedayatyanfard","year":"2020","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.xjidi.2023.100231_bib14","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/wrr.12648","article-title":"Losartan ointment relieves hypertrophic scars and keloid: a pilot study","volume":"26","author":"Hedayatyanfard","year":"2018","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.xjidi.2023.100231_bib15","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/bcpt.13458","article-title":"Angiotensin-converting enzyme inhibitor and angiotensin II type 1 receptor blocker: potential agents to reduce post-surgical scar formation in humans","volume":"127","author":"Hu","year":"2020","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.xjidi.2023.100231_bib16","first-page":"60","article-title":"Low-dose enalapril in the treatment of surgical cutaneous hypertrophic scar and keloid--two case reports and literature review","volume":"8","author":"Iannello","year":"2006","journal-title":"MedGenMed"},{"key":"10.1016\/j.xjidi.2023.100231_bib17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/jamadermatol.2016.3757","article-title":"Reliability and photographic equivalency of the Scar Cosmesis Assessment and Rating (Scar) scale, an outcome measure for postoperative scars","volume":"153","author":"Kantor","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.xjidi.2023.100231_bib18","doi-asserted-by":"crossref","first-page":"8312","DOI":"10.4081\/dr.2020.8312","article-title":"Quality of life in black African patients with keloid scars","volume":"12","author":"Kassi","year":"2020","journal-title":"Dermatol Reports"},{"key":"10.1016\/j.xjidi.2023.100231_bib19","first-page":"356","article-title":"Effects of a topical angiotensin-converting enzyme inhibitor and a selective cox-2 inhibitor on the prevention of hypertrophic scarring in the skin of a rabbit ear","volume":"24","author":"Kim","year":"2012","journal-title":"Wounds"},{"key":"10.1016\/j.xjidi.2023.100231_bib20","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1111\/dsu.12346","article-title":"Intralesional treatment for keloids and hypertrophic scars: a review","volume":"39","author":"Ledon","year":"2013","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.xjidi.2023.100231_bib21","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jid.2016.11.039","article-title":"The abnormal architecture of healed diabetic ulcers is the result of FAK degradation by calpain 1","volume":"137","author":"Liu","year":"2017","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.xjidi.2023.100231_bib23","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/hy09t1.094234","article-title":"Angiotensin II and renal fibrosis","volume":"38","author":"Mezzano","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.xjidi.2023.100231_bib24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1529-8019.2010.01338.x","volume":"23","author":"Miteva","year":"2010","journal-title":"Lipodermatosclerosis. Dermatol Ther"},{"key":"10.1016\/j.xjidi.2023.100231_bib25","doi-asserted-by":"crossref","first-page":"326","DOI":"10.29252\/wjps.7.3.326","article-title":"Efficacy of topical enalapril in treatment of hypertrophic scars","volume":"7","author":"Mohammadi","year":"2018","journal-title":"World J Plast Surg"},{"key":"10.1016\/j.xjidi.2023.100231_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PloS Med"},{"key":"10.1016\/j.xjidi.2023.100231_bib27","doi-asserted-by":"crossref","first-page":"803e","DOI":"10.1097\/PRS.0000000000006173","article-title":"Angiotensin II type I receptor blockade is associated with decreased cutaneous scar formation in a rat model","volume":"144","author":"Murphy","year":"2019","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.xjidi.2023.100231_bib28","first-page":"e25","article-title":"CASE REPORT total management of a severe case of systemic keloids associated with high blood pressure (hypertension): clinical symptoms of keloids may be aggravated by hypertension","volume":"13","author":"Ogawa","year":"2013","journal-title":"Eplasty"},{"key":"10.1016\/j.xjidi.2023.100231_bib29","article-title":"Keloids: current and emerging therapies","volume":"6","author":"Ojeh","year":"2020","journal-title":"Scars Burn Heal"},{"key":"10.1016\/j.xjidi.2023.100231_bib30","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fmed.2020.00335","article-title":"ACE\/ACE2 Ratio: a Key Also in 2019 Coronavirus Disease (Covid-19)?","volume":"7","author":"Pagliaro","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.xjidi.2023.100231_bib31","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pharmthera.2009.05.002","article-title":"Cardiac fibroblasts: at the heart of myocardial remodeling","volume":"123","author":"Porter","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.xjidi.2023.100231_bib32","doi-asserted-by":"crossref","first-page":"975","DOI":"10.7150\/ijms.50197","article-title":"Angiotensin-converting enzyme inhibitor, captopril, improves scar healing in hypertensive rats","volume":"18","author":"Rha","year":"2021","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.xjidi.2023.100231_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-7113-8_1","article-title":"Human fibrotic diseases: current challenges in fibrosis research","volume":"1627","author":"Rosenbloom","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.xjidi.2023.100231_bib34","first-page":"101","article-title":"Topical captopril as a novel agent against hypertrophic scar formation in New Zealand white rabbit skin","volume":"20","author":"Safaee Ardekani","year":"2008","journal-title":"Wounds"},{"key":"10.1016\/j.xjidi.2023.100231_bib35","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1067\/mjd.2002.120788","article-title":"Keloidal scars: a review with a critical look at therapeutic options","volume":"46","author":"Shaffer","year":"2002","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2023.100231_bib36","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/exd.14159","article-title":"The role of the renin-angiotensin system in skin physiology and pathophysiology","volume":"29","author":"Silva","year":"2020","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.xjidi.2023.100231_bib37","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/01.mop.0000236389.41462.ef","article-title":"Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management","volume":"18","author":"Slemp","year":"2006","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.xjidi.2023.100231_bib38","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/DSS.0000000000000253","article-title":"Importance of physical appearance in patients with skin cancer","volume":"41","author":"Sobanko","year":"2015","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.xjidi.2023.100231_bib39","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.xjidi.2023.100231_bib40","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00004630-199005000-00014","article-title":"Rating the burn scar","volume":"11","author":"Sullivan","year":"1990","journal-title":"J\u00a0Burn Care Rehabil"},{"key":"10.1016\/j.xjidi.2023.100231_bib41","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s40257-016-0250-0","article-title":"Stasis dermatitis: pathophysiology, evaluation, and management","volume":"18","author":"Sundaresan","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.xjidi.2023.100231_bib42","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1111\/bph.14489","article-title":"Angiotensin-converting enzyme inhibitor works as a scar formation inhibitor by down-regulating Smad and TGF-\u03b2-activated kinase 1 (Tak1) pathways in mice","volume":"175","author":"Tan","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.xjidi.2023.100231_bib43","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"2020 International Society of Hypertension Global Hypertension Practice Guidelines","volume":"75","author":"Unger","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.xjidi.2023.100231_bib44","doi-asserted-by":"crossref","first-page":"361e","DOI":"10.1097\/PRS.0b013e31829acf0a","article-title":"Angiotensin-converting enzyme inhibitor enalapril reduces formation of hypertrophic scars in a rabbit ear wounding model","volume":"132","author":"Uzun","year":"2013","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.xjidi.2023.100231_bib45","author":"Wells"},{"key":"10.1016\/j.xjidi.2023.100231_bib46","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.xjidi.2023.100231_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109394","article-title":"The effect of topical ramipril and losartan cream in inhibiting scar formation","volume":"118","author":"Zheng","year":"2019","journal-title":"Biomed Pharmacother"}],"container-title":["JID Innovations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667026723000577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667026723000577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T08:05:09Z","timestamp":1763021109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667026723000577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2667026723000577"],"URL":"https:\/\/doi.org\/10.1016\/j.xjidi.2023.100231","relation":{},"ISSN":["2667-0267"],"issn-type":[{"value":"2667-0267","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the Angiotensin Pathway in the Treatment of Cutaneous Fibrosis: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"JID Innovations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xjidi.2023.100231","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}],"article-number":"100231"}}